| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GOLD FLORA Aktie jetzt für 0€ handeln | |||||
| 12.09.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.09.2025 | 837 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 12.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.09.2025ISIN NameCA03770A1093 APOLLO... ► Artikel lesen | |
| 27.03.25 | XFRA V96: AUSSETZUNG/SUSPENSION | 3.209 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGOLD FLORA CORP... ► Artikel lesen | |
| 27.03.25 | Gold Flora Corporation Files for Voluntary Receivership | 372 | PR Newswire | COSTA MESA, Calif., March 27, 2025 /CNW/ - Gold Flora Corporation ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB: GRAM), a cannabis company with... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,105 | -2,66 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| CANOPY GROWTH | 0,914 | -1,61 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,400 | -1,69 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| CRONOS GROUP | 2,240 | -0,62 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| BAUSCH HEALTH | 5,041 | -1,04 % | Bausch Health Companies Inc. - 8-K, Current Report | ||
| ORGANIGRAM GLOBAL | 1,180 | +3,51 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| SNDL | 1,291 | -0,23 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,800 | +1,01 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| TRULIEVE CANNABIS | 5,235 | +1,16 % | Trulieve Cannabis Corp.: Trulieve Reports Fourth Quarter and Full Year 2025 Results with 60% Gross Margin and Record Cash Flow Generation | Full year revenue of $1.2 billion, with 60% gross margin
Record 2025 cash flow from operations of $273 million and free cash flow of $229 million*
Record 50.1... ► Artikel lesen | |
| TERRASCEND | 0,550 | +3,77 % | TerrAscend Reports Third Quarter 2025 Financial Results | Net Revenue of $65.1 million Gross Profit Margin of 52.1% from continuing operations, up 110 basis points from 51.0% in the third quarter of 2024 Net Cash provided from continuing operations of $7.1... ► Artikel lesen | |
| BAYER | 38,620 | -4,90 % | Bayer-Aktie: Bald ein potenzieller Übernahmekandidat? | Der Jubel über einen möglichen Vergleich beim Glyphosat-Rechtsstreit währte nur sehr kurz. Seit dem Hoch von knapp 50 € ging der Kurs wieder gewaltig zurück. Am Dienstag gewinnt die Bayer-Aktie aktuell... ► Artikel lesen | |
| NOVO NORDISK | 31,305 | -2,69 % | Eli Lilly und Novo Nordisk: Angst vor einem Preiskrieg bringt Aktien unter Druck | Novo Nordisk will ab 2027 die Preise für seine Blockbuster-Medikamente Wegovy und Ozempic in den USA drastisch senken und setzt damit Wettbewerber Eli Lilly unter Zugzwang. Die Aktien der beiden Pharmakonzerne... ► Artikel lesen | |
| MERCK KGAA | 121,70 | -3,60 % | Big Blue IBM, Fastly & Merck KGaA - Was sagen Charts UND Fundamentaldaten wirklich? | ||
| ATRIUM THERAPEUTICS | 15,060 | 0,00 % | Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies | Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform
Lead candidates ATR 1072... ► Artikel lesen | |
| HARROW | 53,29 | 0,00 % | Why Is Eye-Disease-Focused Harrow Stock Falling Today? |